Literature DB >> 24390802

Management of increased intracranial pressure.

Danielle K Sandsmark1, Kevin N Sheth.   

Abstract

OPINION STATEMENT: After brain injury, neurologic intensive care focuses on the detection and treatment of secondary brain insults that may compound the initial injury. Increased intracranial pressure (ICP) contributes to secondary brain injury by causing brain ischemia, hypoxia, and metabolic dysfunction. Because ICP is easily measured at the bedside, it is the target of numerous pharmacologic and surgical interventions in efforts to improve brain physiology and limit secondary injury. However, ICP may not adequately reflect the metabolic health of the underlying brain tissue, particularly in cases of focal brain injury. As a result, ICP control alone may be insufficient to impact patients' long-term recovery. Further studies are needed to better understand the combination of cerebral, hemodynamic, and metabolic markers that are best utilized to ensure optimal brain and systemic recovery and overall patient outcome after brain injury.

Entities:  

Year:  2014        PMID: 24390802     DOI: 10.1007/s11940-013-0272-3

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  60 in total

1.  Controlled lumbar drainage in medically refractory increased intracranial pressure. A safe and effective treatment.

Authors:  Ali Murad; Samer Ghostine; Austin R T Colohan
Journal:  Acta Neurochir Suppl       Date:  2008

2.  The outcome from severe head injury with early diagnosis and intensive management.

Authors:  D P Becker; J D Miller; J D Ward; R P Greenberg; H F Young; R Sakalas
Journal:  J Neurosurg       Date:  1977-10       Impact factor: 5.115

Review 3.  Hyperventilation and cerebral blood flow.

Authors:  M E Raichle; F Plum
Journal:  Stroke       Date:  1972 Sep-Oct       Impact factor: 7.914

4.  Pentobarbital coma for refractory intra-cranial hypertension after severe traumatic brain injury: mortality predictions and one-year outcomes in 55 patients.

Authors:  Gary T Marshall; Robert F James; Matthew P Landman; Patrick J O'Neill; Bryan A Cotton; Erik N Hansen; John A Morris; Addison K May
Journal:  J Trauma       Date:  2010-08

5.  Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with subarachnoid hemorrhage.

Authors:  Gunnar Bentsen; Harald Breivik; Tryggve Lundar; Audun Stubhaug
Journal:  Crit Care Med       Date:  2006-12       Impact factor: 7.598

6.  Prognosis in anoxic and traumatic coma.

Authors:  J Attia; D J Cook
Journal:  Crit Care Clin       Date:  1998-07       Impact factor: 3.598

7.  Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema.

Authors:  Madeleine Austinat; Stefan Braeuninger; João B Pesquero; Marc Brede; Michael Bader; Guido Stoll; Thomas Renné; Christoph Kleinschnitz
Journal:  Stroke       Date:  2008-11-06       Impact factor: 7.914

8.  Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke.

Authors:  J Marc Simard; Mingkui Chen; Kirill V Tarasov; Sergei Bhatta; Svetlana Ivanova; Ludmila Melnitchenko; Natalya Tsymbalyuk; G Alexander West; Volodymyr Gerzanich
Journal:  Nat Med       Date:  2006-03-19       Impact factor: 53.440

Review 9.  Sulfonylurea receptor 1 in central nervous system injury: a focused review.

Authors:  J Marc Simard; S Kyoon Woo; Gary T Schwartzbauer; Volodymyr Gerzanich
Journal:  J Cereb Blood Flow Metab       Date:  2012-06-20       Impact factor: 6.200

10.  Bifrontal decompressive craniectomy in the management of posttraumatic intracranial hypertension.

Authors:  P C Whitfield; H Patel; P J Hutchinson; M Czosnyka; D Parry; D Menon; J D Pickard; P J Kirkpatrick
Journal:  Br J Neurosurg       Date:  2001-12       Impact factor: 1.596

View more
  1 in total

1.  Src Family Kinases in Brain Edema After Acute Brain Injury.

Authors:  DaZhi Liu; Xiong Zhang; BeiLei Hu; Bradley P Ander
Journal:  Acta Neurochir Suppl       Date:  2016
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.